SCHEMBL30337387

SCHEMBL30337387

C[C@@H](O)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](N)CCCCN)C(=O)O

nearest known ligand 0.57

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
▸ NPY4R P50391 7/20 0.52
▸ NPY1R P25929 6/20 0.52
▸ NPY2R P49146 5/20 0.52
▸ OPRD1 P41143 3/20 0.51
▸ OPRM1 P35372 2/20 0.51
▸ NTSR2 O95665 2/20 0.49
▸ NTSR1 P30989 2/20 0.49
▸ BACE1 P56817 2/20 0.49
▸ BACE2 Q9Y5Z0 2/20 0.49
▸ NPY5R Q15761 4/20 0.48
▸ ENPEP Q07075 3/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29530787 0.91 OPRD1 (0.50) NPY4RNPY1RNPY2ROPRD1OPRM1
SCHEMBL29531643 0.90 OPRD1 (0.56) OPRD1OPRM1BACE1BACE2
SCHEMBL29531229 0.90 OPRD1 (0.56) OPRD1OPRM1BACE1BACE2
SCHEMBL30733264 0.90 NPY1R (0.50) NPY4RNPY1RNPY2ROPRD1NTSR2
SCHEMBL30401037 0.89 NPY1R (0.53) NPY4RNPY1RNPY2ROPRD1NTSR2
SCHEMBL30733209 0.89 NPY1R (0.51) NPY4RNPY1RNPY2ROPRD1NTSR2
SCHEMBL29363254 0.89 NPY1R (0.54) NPY4RNPY1RNPY2ROPRD1NTSR2
SCHEMBL29629479 0.88 NPY4R (0.57) NPY4RNPY1RNPY2ROPRD1OPRM1
SCHEMBL29500560 0.88 NPY4R (0.56) NPY4RNPY1RNPY2ROPRM1NTSR2
SCHEMBL29865452 0.88 ENPEP (0.58) NPY4RNPY1RNPY2ROPRM1NTSR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023080791-A1 PEPTIDES FOR THE INHIBITION OF PARASITE INFECTION KAPP DET GODE HÅP AS (NO) 2023-05-11 — — WO claimed
WO-2023080791-A1 PEPTIDES FOR THE INHIBITION OF PARASITE INFECTION KAPP DET GODE HÅP AS (NO) 2023-05-11 — — WO disclosed
Send feedback